Company Directory / Medical Device

PrivateFor profitMedical DeviceLausanne, VD, Switzerland
Aleva Neurotherapeutics has developed proprietary neurostimulation platform based on microDBS Technology.
ALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads* Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets. We understand that if we want to help OUR CUSTOMERS, overcome their… Read all
ALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads* Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets. We understand that if we want to help OUR CUSTOMERS, overcome their challenges, we need to 👉COMBINE SPECIALISATION with the 👉COMMITMENT TO BE RESPONSIVE to the everyday new challenges they experience. This is the attitude you will find in every ALEVA employee and sales representative who will be in contact with you. We are the 👉ONLY EUROPEAN COMPANY that designs, manufactures, and commercialises DBS devices for the treatment of Parkinson’s disease and essential tremor. Our production and R&D headquarters based in Switzerland complies to the highest quality standard for the highest safety of patients worldwide. Our A VISIONARY PROJECT SUSTAINED BY SOLID FOUNDATIONS: 👉a new group of investors that will sustain the completion of OUR PROJECT 👉a reinforced executive team who is complementing the existing successful group to partner with Neurosurgeons and Neurologists in the effective deployment of our Vision. *May 28, 2014 http://doi.org/10.1093/brain/awu102.
Size
51-100 people: larger than 75% of companies with a size listed. 3 people list it on LinkedIn.
Age
18 years old.
Reach
No web traffic ranking listed. 4,893 followers on LinkedIn.
Health CareHealth DiagnosticsMedical DeviceNeuroscienceNeurosurgeryDeep Brain StimulationMedical Device Development
neurosurgerydeep brain stimulationmedical device developmentmedical equipment manufacturingeuropean medical deviceneurostimulationneurosurgeon toolsdirectional deep brain stimulationimplantable pulse generatorbrain electrode designprogrammable neurostimulatorssurgical precisionbrain implant technologypersonalized therapyprecision neuromodulationmedical device r&d
WixMicrosoft Email ProvidersMicrosoft Exchange OnlineOutlookMicrosoft 365Microsoft 365 Apps & ServicesMicrosoft ExchangeCloudFlareGoogle App EngineHREF LangWebsiteBuilderSirvoyTrustArcGoogle MapsPriority Hintspickadate.jsWordPress.orgPrimeNG
Funding, as listed
$65M raised in total
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Aleva Neurotherapeutics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
Classification
About this record
Growth, as the source summarises it
Aleva Neurotherapeutics may be growing due to the expanding market for deep brain stimulation (DBS) devices, which is relevant to their proprietary neurostimulation platform based on microDBS technology. The global DBS devices market is projected to reach a valuation of USD 3.44 billion by 2033, growing at a CAGR of 10.22%, which suggests a growing demand for products in the same category as Aleva's offerings. Additionally, the underutilization of Parkinson's DBS treatments in the UK indicates potential for market expansion and increased adoption of such technologies. The overall expansion of the DBS devices market to an estimated USD 3.5 billion by 2033 further supports the potential for growth in the sector where Aleva Neurotherapeutics operates.
Summaries written by the source dataset, not by us, and not checked.
Medical Device in Switzerland.
NovoCureZug · 1001-5000 people · 60k followers
CeQur SimplicityHorw · 51-100 people · 9k followersEEndosenseMeyrin · 51-100 people · 2k followers
AliveDxEysins, Switzerland · 251-500 people · 13k followers
Medimaps GroupPlan-les-Ouates · 11-50 people · 10k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,795 companies in Switzerland and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.